Cancer Cell International

Papers
(The TQCC of Cancer Cell International is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment310
New insights into M1/M2 macrophages: key modulators in cancer progression199
Challenges of applying multicellular tumor spheroids in preclinical phase174
p53 signaling in cancer progression and therapy162
Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine147
Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment143
The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review136
circRNA-miRNA-mRNA regulatory network in human lung cancer: an update130
Clinical applications of artificial intelligence and machine learning in cancer diagnosis: looking into the future121
The biological function of m6A demethylase ALKBH5 and its role in human disease106
The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations104
The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers93
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier86
RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer79
Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer75
Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets73
Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk71
Polyamines and related signaling pathways in cancer69
Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma66
Dynamic regulation and functions of mRNA m6A modification65
Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis64
Emerging roles of RNA methylation in gastrointestinal cancers62
CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC)61
Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review61
Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer57
Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway57
FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport57
CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis56
METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification56
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures56
Recent advances and limitations of mTOR inhibitors in the treatment of cancer54
Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma53
SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting CCNE1 via TGFβ/PI3K/AKT/GSK3β pathway53
Induction and application of ferroptosis in cancer therapy51
Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma51
Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC51
Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells50
LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L150
A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma50
Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis50
The biological function of m6A reader YTHDF2 and its role in human disease49
Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer49
Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment49
Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF148
Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis48
Myricetin: targeting signaling networks in cancer and its implication in chemotherapy47
The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis46
Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma46
Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway45
SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer45
Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)45
An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress43
Protein kinase function of pyruvate kinase M2 and cancer43
Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients43
Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance42
Cancer-related circular RNA: diverse biological functions42
CRNDE: an oncogenic long non-coding RNA in cancers42
Triple-negative breast cancer: understanding Wnt signaling in drug resistance41
Circ_0007841 promotes the progression of multiple myeloma through targeting miR-338-3p/BRD4 signaling cascade41
Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines41
Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways40
Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288/miR-145/PD-L1 axis in hepatocellular carcinoma40
Emerging role of long noncoding RNA-encoded micropeptides in cancer40
Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin40
LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway39
The expression profiles and prognostic values of HSPs family members in Head and neck cancer39
Autophagy regulation using luteolin: new insight into its anti-tumor activity39
Potential of antibody–drug conjugates (ADCs) for cancer therapy39
Geriatric nutritional risk index as a predictor of complications and long-term outcomes in patients with gastrointestinal malignancy: a systematic review and meta-analysis38
BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes38
Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer38
FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis38
Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer37
EO771, the first luminal B mammary cancer cell line from C57BL/6 mice37
Signaling pathways of EBV-induced oncogenesis37
Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients37
MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma36
CircZFR functions as a sponge of miR-578 to promote breast cancer progression by regulating HIF1A expression36
Macrophages-derived exosomal lncRNA LIFR-AS1 promotes osteosarcoma cell progression via miR-29a/NFIA axis36
LncRNA SNHG3, a potential oncogene in human cancers36
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction36
Matrine inhibits cell growth, migration, invasion and promotes autophagy in hepatocellular carcinoma by regulation of circ_0027345/miR-345-5p/HOXD3 axis36
LncRNA LIFR-AS1 promotes proliferation and invasion of gastric cancer cell via miR-29a-3p/COL1A2 axis35
Circular RNA circ_0000284 plays an oncogenic role in the progression of non-small cell lung cancer through the miR-377-3p-mediated PD-L1 promotion35
Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma35
Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review35
Downregulation of circular RNA hsa_circ_0000735 boosts prostate cancer sensitivity to docetaxel via sponging miR-735
Circular RNA circ-MAT2B facilitates glycolysis and growth of gastric cancer through regulating the miR-515-5p/HIF-1α axis35
Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy35
MicroRNAs and angiogenesis: a new era for the management of colorectal cancer35
Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches34
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review34
Circular RNA ITCH suppresses proliferation, invasion, and glycolysis of ovarian cancer cells by up-regulating CDH1 via sponging miR-106a34
Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma34
lncRNA LIFR-AS1 suppresses invasion and metastasis of non-small cell lung cancer via the miR-942-5p/ZNF471 axis34
Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview34
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics33
The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review33
The cancer‐associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer33
Role of m6A methyltransferase component VIRMA in multiple human cancers (Review)33
Ovarian cancer: epigenetics, drug resistance, and progression32
SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells32
Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma32
Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies32
Reshaping the role of m6A modification in cancer transcriptome: a review32
Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma31
The regulatory role of antisense lncRNAs in cancer31
LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway31
CircRNA DONSON contributes to cisplatin resistance in gastric cancer cells by regulating miR-802/BMI1 axis31
MicroRNA-122 in human cancers: from mechanistic to clinical perspectives31
A review on the advances and challenges of immunotherapy for head and neck cancer31
Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes31
Long noncoding RNA MIR99AHG promotes gastric cancer progression by inducing EMT and inhibiting apoptosis via miR577/FOXP1 axis31
Anticancer effects of bifidobacteria on colon cancer cell lines31
LncRNA & Wnt signaling in colorectal cancer31
CircHIPK3 promotes proliferation and metastasis and inhibits apoptosis of renal cancer cells by inhibiting MiR-485-3p30
Assessing immune infiltration and the tumor microenvironment for the diagnosis and prognosis of sarcoma30
Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studies30
Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p30
A systematic review of anti-cancer roles and mechanisms of kaempferol as a natural compound30
Genistein as a regulator of signaling pathways and microRNAs in different types of cancers30
CAFs affect the proliferation and treatment response of head and neck cancer spheroids during co-culturing in a unique in vitro model30
Chemoprotective and chemosensitizing effects of apigenin on cancer therapy30
Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature30
The diagnostic value of EBV-DNA and EBV-related antibodies detection for nasopharyngeal carcinoma: a meta-analysis30
SOX4 promotes the growth and metastasis of breast cancer30
Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p30
Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy30
Glioma exosomal microRNA-148a-3p promotes tumor angiogenesis through activating the EGFR/MAPK signaling pathway via inhibiting ERRFI130
Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway30
Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro29
LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis29
CAR-T cell combination therapy: the next revolution in cancer treatment29
CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma29
Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness29
RNA m6A methylation regulators in ovarian cancer29
LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis29
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells29
Circular RNA hsa_circ_0061395 accelerates hepatocellular carcinoma progression via regulation of the miR-877-5p/PIK3R3 axis29
Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer28
Long non-coding RNA MALAT1 regulates oxaliplatin-resistance via miR-324-3p/ADAM17 axis in colorectal cancer cells28
CircRNA hsa_circRNA_0001776 inhibits proliferation and promotes apoptosis in endometrial cancer via downregulating LRIG2 by sponging miR-18228
MiR-145-5p suppresses the proliferation, migration and invasion of gastric cancer epithelial cells via the ANGPT2/NOD_LIKE_RECEPTOR axis28
Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma28
CircRNA PIP5K1A promotes the progression of glioma through upregulation of the TCF12/PI3K/AKT pathway by sponging miR-515-5p28
The emerging roles of circular RNAs in ovarian cancer28
The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis28
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC28
Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired28
HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway28
The role of Th17 cells in the pathogenesis and treatment of breast cancer28
A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammato28
The relationship between TRAF6 and tumors27
Long noncoding RNA HOTAIR promotes breast cancer development by targeting ZEB1 via sponging miR-60127
Circ_100565 promotes proliferation, migration and invasion in non-small cell lung cancer through upregulating HMGA2 via sponging miR-506-3p27
Identification of key biomarkers associated with cell adhesion in multiple myeloma by integrated bioinformatics analysis27
Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer27
Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer27
Automatic model for cervical cancer screening based on convolutional neural network: a retrospective, multicohort, multicenter study27
Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma27
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization27
A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma27
Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis27
Exploring TCGA database for identification of potential prognostic genes in stomach adenocarcinoma26
Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis26
The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma26
Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance26
Role of glutamine and its metabolite ammonia in crosstalk of cancer-associated fibroblasts and cancer cells26
LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells26
MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer26
Curcumin anti‐tumor effects on endometrial cancer with focus on its molecular targets26
A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer26
Mitochondrion-mediated iron accumulation promotes carcinogenesis and Warburg effect through reactive oxygen species in osteosarcoma26
CircPOSTN/miR-361-5p/TPX2 axis regulates cell growth, apoptosis and aerobic glycolysis in glioma cells26
A review on the role of cyclin dependent kinases in cancers26
M2 macrophages‐derived exosomal microRNA-501-3p promotes the progression of lung cancer via targeting WD repeat domain 8226
Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT26
Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis26
LINC01094 triggers radio-resistance in clear cell renal cell carcinoma via miR-577/CHEK2/FOXM1 axis26
CircRNA_100290 promotes GC cell proliferation and invasion via the miR-29b-3p/ITGA11 axis and is regulated by EIF4A326
Exosomal miR-301a-3p from esophageal squamous cell carcinoma cells promotes angiogenesis by inducing M2 polarization of macrophages via the PTEN/PI3K/AKT signaling pathway25
LncRNA HOTAIR induces sunitinib resistance in renal cancer by acting as a competing endogenous RNA to regulate autophagy of renal cells25
HMGB1 mediates lipopolysaccharide-induced inflammation via interacting with GPX4 in colon cancer cells25
Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma25
Molecular mechanisms of the microRNA-132 during tumor progressions25
As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway25
Heterogeneous programmed death-ligand 1 expression in gastric cancer: comparison of tissue microarrays and whole sections25
M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT25
Hsa_circ_0026416 promotes proliferation and migration in colorectal cancer via miR-346/NFIB axis25
Circ_LDLR promoted the development of papillary thyroid carcinoma via regulating miR-195-5p/LIPH axis25
YTHDC1-mediated VPS25 regulates cell cycle by targeting JAK-STAT signaling in human glioma cells25
Luteolin: a flavonoid with a multifaceted anticancer potential25
Prognostic impact of tertiary lymphoid structures in breast cancer prognosis: a systematic review and meta-analysis25
LncRNA KCNQ1OT1 promotes cell proliferation, migration and invasion via regulating miR-129-5p/JAG1 axis in non-small cell lung cancer24
The expression patterns and the diagnostic/prognostic roles of PTPN family members in digestive tract cancers24
Roles of ferroptosis in urologic malignancies24
Fatty acid oxidation: driver of lymph node metastasis24
The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma24
Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p/CUL4B pathway24
CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope24
The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer24
Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma24
MALAT1-related signaling pathways in colorectal cancer24
The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma24
LncRNA MEG3 suppressed the progression of ovarian cancer via sponging miR-30e-3p and regulating LAMA4 expression24
The importance of CDC27 in cancer: molecular pathology and clinical aspects24
LPCAT1 overexpression promotes the progression of hepatocellular carcinoma24
Nine glycolysis-related gene signature predicting the survival of patients with endometrial adenocarcinoma24
LncRNA FLVCR1-AS1 promotes proliferation, migration and activates Wnt/β-catenin pathway through miR-381-3p/CTNNB1 axis in breast cancer24
Co-presence of human papillomaviruses and Epstein–Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patients24
Long non-coding RNA LINC00470 in serum derived exosome: a critical regulator for proliferation and autophagy in glioma cells24
Exosomes derived from M2 type tumor-associated macrophages promote osimertinib resistance in non-small cell lung cancer through MSTRG.292666.16-miR-6836-5p-MAPK8IP3 axis24
LncRNA TRG-AS1 stimulates hepatocellular carcinoma progression by sponging miR-4500 to modulate BACH123
RETRACTED ARTICLE: Circular RNA circ_0000517 regulates hepatocellular carcinoma development via miR-326/IGF1R axis23
FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A23
Targeting Nrf2 may reverse the drug resistance in ovarian cancer23
Construction of a metastasis-associated ceRNA network reveals a prognostic signature in lung cancer23
Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma23
Circular RNA and tumor microenvironment23
Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer23
Co-expression network analysis identifies a gene signature as a predictive biomarker for energy metabolism in osteosarcoma23
Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma23
RETRACTED ARTICLE: CircRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis23
LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis23
LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling23
RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells23
LncRNA JPX promotes cervical cancer progression by modulating miR-25-3p/SOX4 axis23
Inhibition of cancer cell-derived exosomal microRNA-183 suppresses cell growth and metastasis in prostate cancer by upregulating TPM123
Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells23
LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p23
Circular RNA circ_0006168 enhances Taxol resistance in esophageal squamous cell carcinoma by regulating miR-194-5p/JMJD1C axis23
Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment22
SNHG17 promotes the proliferation and migration of colorectal adenocarcinoma cells by modulating CXCL12-mediated angiogenesis22
Prognostic role of METTL1 in glioma22
Preoperative systemic immune-inflammation index predicts prognosis of patients with non-metastatic renal cell carcinoma: a propensity score-matched analysis22
Joint analysis of lncRNA m6A methylome and lncRNA/mRNA expression profiles in gastric cancer22
Zebrafish xenograft model of human lung cancer for studying the function of LINC00152 in cell proliferation and invasion22
A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression22
Advances in biomarkers and techniques for pancreatic cancer diagnosis22
Exosomes from cervical cancer cells facilitate pro-angiogenic endothelial reconditioning through transfer of Hedgehog–GLI signaling components22
miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC122
Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review22
Circ_0000285 regulates proliferation, migration, invasion and apoptosis of osteosarcoma by miR-409-3p/IGFBP3 axis22
Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression22
The lncRNA NEAT1 promotes the epithelial-mesenchymal transition and metastasis of osteosarcoma cells by sponging miR-483 to upregulate STAT3 expression22
MiR-1307-5p targeting TRAF3 upregulates the MAPK/NF-κB pathway and promotes lung adenocarcinoma proliferation22
LncRNA ZFAS1 promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2 pathway by sponging miR-392422
Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation22
Engineered exosomes loaded with miR-449a selectively inhibit the growth of homologous non-small cell lung cancer22
LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis22
0.036882877349854